Literature DB >> 16045726

Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

T Matsubara1, T Ichiyama, S Furukawa.   

Abstract

Kawasaki disease (KD) is an acute illness of early childhood characterized by prolonged fever, diffuse mucosal inflammation, indurative oedema of the hands and feet, a polymorphous skin rash and nonsuppurative lymphadenopathy. The histopathological findings in KD comprise panvasculitis with endothelial necrosis, and the infiltration of mononuclear cells into small and medium-sized blood vessels. The levels of many proinflammatory cytokines, chemokines and adhesion molecules can be elevated in sera from children with KD at the acute stage. Although many immunological studies on KD involving peripheral blood have been reported, the data obtained remain controversial. This review focuses on the immune response of peripheral blood lymphocytes and monocytes/macrophages during acute KD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045726      PMCID: PMC1809464          DOI: 10.1111/j.1365-2249.2005.02821.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  68 in total

1.  Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease.

Authors:  D Shingadia; M O'Gorman; A H Rowley; S T Shulman
Journal:  Pediatr Res       Date:  2001-10       Impact factor: 3.756

2.  Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.

Authors:  Hiroshi Tsujimoto; Seiichiro Takeshita; Keigo Nakatani; Youichi Kawamura; Tomoharu Tokutomi; Isao Sekine
Journal:  Clin Immunol       Date:  2002-05       Impact factor: 3.969

3.  Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.

Authors:  P A Brogan; V Shah; N Klein; M J Dillon
Journal:  Arthritis Rheum       Date:  2004-02

4.  Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease.

Authors:  Q J Yi; C R Li; X Q Yang
Journal:  Acta Paediatr       Date:  2001-06       Impact factor: 2.299

5.  Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo.

Authors:  S R Webb; J Hutchinson; K Hayden; J Sprent
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

6.  T cell Vbeta repertoires in childhood vasculitides.

Authors:  P A Brogan; V Shah; A Bagga; N Klein; M J Dillon
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

7.  Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.

Authors:  S Furukawa; T Matsubara; Y Umezawa; K Okumura; K Yabuta
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

8.  Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; K Okumura; K Yabuta
Journal:  Scand J Immunol       Date:  1993-03       Impact factor: 3.487

9.  CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

Authors:  T Matsubara; R Anwar; M Fujiwara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

Authors:  D Y Leung; H C Meissner; D R Fulton; D L Murray; B L Kotzin; P M Schlievert
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

View more
  52 in total

1.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

3.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

4.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

Review 5.  p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease.

Authors:  Gouri P Hule; Purva R Kanvinde; Manasi A Kulkarni; Karin van Leeuwen; Martin de Boer; Umair Ahmed Bargir; Prasad D Taur; Mukesh M Desai; Manisha R Madkaikar
Journal:  J Clin Immunol       Date:  2018-08-09       Impact factor: 8.317

6.  Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?

Authors:  Stefano Stagi; Donato Rigante; Gemma Lepri; Marco Matucci Cerinic; Fernanda Falcini
Journal:  Clin Rheumatol       Date:  2015-05-22       Impact factor: 2.980

7.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

8.  Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus.

Authors:  Sadi Turkay; Ender Odemis; Ahmet Karadag
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

9.  Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

Authors:  Yue Peng; Qiongfei Pei; Siqi Feng; Ya Su; Ruixi Liu; Qijian Yi; Pengfei Guo
Journal:  Clin Exp Med       Date:  2019-09-03       Impact factor: 3.984

10.  Predicting factors for refractory kawasaki disease.

Authors:  Young-Sun Do; Ki-Won Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.